GRAIL (GRAL) Competitors $46.81 -0.75 (-1.57%) Closing price 07/3/2025 03:56 PM EasternExtended Trading$46.82 +0.00 (+0.00%) As of 07/3/2025 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. GH, OPCH, RDNT, BTSG, SHC, PRVA, CON, SGRY, ADUS, and VCYTShould you be buying GRAIL stock or one of its competitors? The main competitors of GRAIL include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Addus HomeCare (ADUS), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. GRAIL vs. Its Competitors Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Privia Health Group Concentra Group Holdings Parent Surgery Partners Addus HomeCare Veracyte Guardant Health (NASDAQ:GH) and GRAIL (NASDAQ:GRAL) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation. Which has preferable earnings & valuation, GH or GRAL? Guardant Health has higher revenue and earnings than GRAIL. Guardant Health is trading at a lower price-to-earnings ratio than GRAIL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$739.02M8.42-$436.37M-$3.39-14.82GRAIL$125.60M13.41-$2.03B-$60.99-0.77 Do institutionals & insiders have more ownership in GH or GRAL? 92.6% of Guardant Health shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by insiders. Comparatively, 1.9% of GRAIL shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer GH or GRAL? Guardant Health presently has a consensus price target of $53.76, indicating a potential upside of 6.99%. GRAIL has a consensus price target of $31.50, indicating a potential downside of 32.71%. Given Guardant Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Guardant Health is more favorable than GRAIL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 21 Buy rating(s) 0 Strong Buy rating(s) 3.00GRAIL 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is GH or GRAL more profitable? Guardant Health has a net margin of -53.82% compared to GRAIL's net margin of -1,464.53%. Guardant Health's return on equity of 0.00% beat GRAIL's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-53.82% N/A -26.77% GRAIL -1,464.53%-17.99%-15.02% Does the media prefer GH or GRAL? In the previous week, GRAIL had 1 more articles in the media than Guardant Health. MarketBeat recorded 12 mentions for GRAIL and 11 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.72 beat GRAIL's score of 0.60 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 5 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GRAIL 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGuardant Health beats GRAIL on 11 of the 15 factors compared between the two stocks. Get GRAIL News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGRAILMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.68B$2.91B$5.53B$9.05BDividend YieldN/A2.44%5.24%4.03%P/E Ratio-0.7721.5627.5220.22Price / Sales13.41281.76421.02118.64Price / Cash1.6242.7336.8958.07Price / Book0.637.518.045.67Net Income-$2.03B-$55.05M$3.18B$249.13M7 Day Performance-3.26%4.61%2.90%3.28%1 Month Performance18.55%4.72%3.70%5.56%1 Year PerformanceN/A5.92%36.15%21.12% GRAIL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGRAIL0.6877 of 5 stars$46.81-1.6%$31.50-32.7%N/A$1.68B$125.60M-0.771,360Positive NewsInsider TradeGHGuardant Health3.7456 of 5 stars$48.55-1.2%$53.76+10.7%+76.9%$6.09B$739.02M-14.322,021Insider TradeOPCHOption Care Health4.3657 of 5 stars$31.05-1.5%$35.50+14.3%+11.5%$5.16B$5.00B25.048,088Positive NewsRDNTRadNet3.6791 of 5 stars$54.87-0.7%$69.60+26.8%-5.2%$4.14B$1.83B-127.6011,021BTSGBrightSpring Health Services1.6305 of 5 stars$22.77+2.2%$24.90+9.4%+95.5%$3.92B$11.27B81.3235,000Analyst UpgradeSHCSotera Health3.0002 of 5 stars$11.09-2.6%$15.80+42.5%+0.8%$3.23B$1.10B138.643,000PRVAPrivia Health Group4.2461 of 5 stars$21.61-1.1%$27.77+28.5%+30.4%$2.66B$1.74B180.101,140CONConcentra Group Holdings Parent2.5334 of 5 stars$20.95+1.0%$28.50+36.0%N/A$2.66B$1.90B15.6311,250SGRYSurgery Partners2.6015 of 5 stars$20.20+4.7%$33.56+66.1%-6.1%$2.47B$3.11B-13.2015,000ADUSAddus HomeCare4.9651 of 5 stars$113.01-0.7%$142.57+26.2%-4.7%$2.09B$1.15B25.5149,703VCYTVeracyte3.6097 of 5 stars$26.71+1.2%$40.90+53.1%+28.1%$2.07B$445.76M65.15790 Related Companies and Tools Related Companies Guardant Health Alternatives Option Care Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives Surgery Partners Alternatives Addus HomeCare Alternatives Veracyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRAIL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRAIL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
